Cargando…
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity
Despite the success of immunotherapy in several haematological neoplasms, the effectiveness in acute myeloid leukaemia (AML) is still controversial, partially due to the lack of knowledge regarding immune‐related processes in this disease and similar neoplasias. In this study, we analysed the role a...
Autores principales: | Cornet‐Masana, Josep M., Banús‐Mulet, Antònia, Cuesta‐Casanovas, Laia, Carbó, José M., Guijarro, Francesca, Torrente, Miguel Ángel, Esteve, Jordi, Risueño, Ruth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701509/ https://www.ncbi.nlm.nih.gov/pubmed/33080103 http://dx.doi.org/10.1111/jcmm.15930 |
Ejemplares similares
-
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
por: Cornet-Masana, Josep M., et al.
Publicado: (2019) -
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023) -
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
por: Carbó, José M., et al.
Publicado: (2023) -
Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016) -
Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022)